Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Leading the Cell Line Development Group within the Cell Line and Upstream Engineering department at ImmunoGen to support the development of targeted anticancer therapeutics. The Company's ADC technology uses tumor-targeting antibodies to deliver an ImmunoGen cell-killing agent specifically to cancer cells. Driving innovation and new technology application to advance the cell line development platform and deliver highly productive cell lines to support ImmunoGen's growing early and late stage pipeline. Current research focuses on high-throughput cell line screening, host cell engineering and automation.